See also this year's filing and all EDGAR filings for this company.
PDF Report 0001388410_2019_Parallax_Health_Sciences_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001388410')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001388410, Parallax Health Sciences INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 1,364,095 |
| 1 | AssetsNonCurrent | 0 |
| 2 | AssetsCurrent | 262 |
| 3 | PropertyPlantAndEquipment | 0 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 2,206,299 |
| 6 | LiabilitiesCurrent | 5,139,617 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 20,339 |
| 10 | GeneralAndAdministrativeExpense | 6,552,693 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 0 |
| 17 | remainder_Revenues | 11,739 |
| 18 | remainder_NetIncome | 22,850,613 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,364,357 |
| 1 | Liabilities | 7,345,916 |
| 2 | Expenses | 6,573,032 |
| 3 | Revenues | 11,739 |
| 4 | StockholdersEquity | -5,981,559 |
| 5 | NetIncome | 16,289,320 |
| 6 | ComprehensiveNetIncome | 16,289,320 |
| 7 | BaseVar | 19,072,828 |
| 8 | EconomicCapitalRatio | -0.0779 |
Edgar->Model Mapping
Feature Distribution
Change over Time
